GC Pharma wins a $49 million flu vaccine deal with PAHO

GC Pharma won a $48.9 million flu vaccine deal with the Pan American Health Organization (PAHO), the company said Monday.

2021-12-13

Bio booms as Covid lingers and CMO vaccine orders surge

Korean biopharmaceutical companies are enjoying a strong third quarter on the lingering Covid-19 pandemic and sales of vaccines they produce under contract manufacturing organization (CMO) deals.

2021-11-04

GC Pharma signs agreement with Austin's Speragen

GC Pharma signed a partnership agreement with Austin, Texas-based Speragen for joint development of a treatment for succinic semialdehyde dehydrogenase deficiency (Ssadhd), the company said Tuesday.

2021-07-20

GC Pharma's Covid treatment turned down

After reviewing GC Pharma's clinical trial data, a committee under the Ministry of Food and Drug Safety recommended regulators not grant conditional use approval, saying the trial results were insufficient to prove the drug's safety and efficacy.

2021-05-12

GC Pharma applies for approval for Covid-19 treatment

The Ministry of Food and Drug Safety said Friday that GC Pharma submitted paperwork to start the approval process for GC5131A. If conditional use is approved, GC5131A will be the second Korea-made Covid-19 treatment to get a nod.

2021-04-30

GC Pharma finishes Covid treatment Phase 2 tests, starts compiling data

GC Pharma completed injections for Phase 2 clinical trials of its Covid-19 treatment candidate in late December, the company confirmed Wednesday.

2021-01-06

GC completes selloff of U.S. subsidiaries for $460 million

GC, the holding company of GC Pharma, completed the selloff of U.S. subsidiaries and raised $460 million from the deal. The company said Monday that it sold its U.S. corporations GCBT and GCAM to Grifols, a Spanish pharmaceutical firm.

2020-10-05

GC Pharma starts Phase 2 trials of Covid-19 plasma treatment

GC Pharma has started Phase 2 clinical trials for its Covid-19 treatment candidate, the company said Monday.

2020-09-21

Covid-19 treatment production starts ahead of approvals

Mass production of Covid-19 treatments will begin in Korea this month, the Korea Centers for Disease Control and Prevention (KCDC) said. The treatments will not be immediately available for public use.

2020-09-08

Local therapy for Covid-19 starts Phase 2 trials

The Ministry of Food and Drug Safety approved a second-phase clinical trial of a Covid-19 treatment by pharmaceutical firm GC Pharma on Thursday.

2020-08-20

korea joongAng daily